How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Pemazyre cost savings if eligible
With our assistance, you could access the Pemazyre patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Pemazyre patient assistance?
We review each Pemazyre enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Pemazyre patient assistance program?
Our process makes it as easy as possible to apply for the Pemazyre patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Pemazyre, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx a Pemazyre coupons provider?
NiceRx is not a Pemazyre coupon, Pemazyre discount card, or Pemazyre copay card provider. We do not offer Pemazyre manufacturer coupons, Pemazyre discounts, rebates, Pemazyre savings cards, trial offers, or free Pemazyre samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Pemazyre
- Your insurance company will not pay for your Pemazyre prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Pemazyre cost without insurance?
Without insurance, Pemazyre costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Pemazyre oral tablets 4.5 mg will cost around $17,760 for a supply of 14 tablets.
How much does Pemazyre cost with insurance?
The copay for Pemazyre will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Pemazyre?
Pemazyre is an FDA (U.S. Food and Drug Administration) approved medication developed by Incyte Corporation. It is a kinase inhibitor for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma (bile duct cancer) with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangements.
This indication is approved under accelerated approval based on the overall response rate (ORR) and duration of response (DOR). Continued approval for this indication may depend upon verification and description of clinical benefit in a confirmatory trial(s).
What doses of Pemazyre are available?
Pemazyre is available in tablet form, in the following doses: 4.5 mg, 9 mg, and 13.5 mg.
Before starting treatment confirm the presence of an FGFR2 fusion or rearrangement. The recommended dose is 13.5 mg orally once daily for 14 days followed by 7 days off therapy in 21-day cycles. Continue treatment until disease progression or unacceptable toxicity occurs. Swallow the tablets whole, with or without food.
Always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Pemazyre active ingredients
The active ingredient of Pemazyre is pemigatinib.
Pemazyre side effects
The most common adverse reactions (incidence ≥ 20%) of Pemazyre in clinical trials include:
- Alopecia (hair loss)
- Diarrhea, constipation
- Nail toxicity
- Dysgeusia, stomatitis, dry mouth, nausea,
- Dry eye, ocular toxicity
- Nausea, vomiting, abdominal pain
- Arthralgia (joint pain), back pain
- Dry skin
In rare instances, Pemazyre can cause more serious side effects. These can include:
- Retinal pigment epithelial detachment
- Hyperphosphatemia – increases in phosphate levels
Your doctor will assess the benefits of using Pemazyre against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Pemazyre to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Pemazyre drug interactions
Pemazyre can interact with other medications. These include:
- Strong and moderate CYP3A Inducers – avoid concomitant use of Pemazyre
- Strong and moderate- CYP3A inhibitors
This list is not exhaustive and other prescription drugs may interact with Pemazyre.
You should not use Pemazyre if you:
- Are allergic to the active ingredient pemigatinib
- Are allergic to any of the other ingredients in Pemazyre
- Are pregnant or are planning to become pregnant – a potential risk to the fetus of pregnant women. Female patients of reproductive potential are advised to use effective contraception during treatment and for 1 week after the final dose
- Are breastfeeding or are planning to breastfeed
Talk to your doctor before using Pemazyre if you:
- Are taking any of the medications that could interact with Pemazyre
- Have a severe hepatic impairment
- Have a severe renal impairment
Pemazyre is the trademark brand name for pemigatinib developed by Incyte Corporation. A generic version of pemigatinib is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Pemazyre savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.